ad image

Clinical Results

1 / 1
AbbVie
Clinical Trials

AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie

PR-09-24-NI-17Sep 26, 2024
Actinium Pharmaceuticals, Inc.
Clinical Result

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in Clinical Oncology

Actinium Pharmaceuticals, Inc.

PR-09-24-NI-09Sep 20, 2024
1 / 1